Viewing Study NCT03793166

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:31 PM
Ignite Modification Date: 2026-02-01 @ 12:44 PM
Study NCT ID: NCT03793166
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-17
First Post: 2019-01-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Clear Cell Renal Cell Carcinoma View
None Metastatic Malignant Neoplasm in the Bone View
None Metastatic Malignant Neoplasm in the Lymph Nodes View
None Metastatic Malignant Neoplasm in the Soft Tissue View
None Metastatic Malignant Neoplasm in the Viscera View
None Rhabdoid Tumor of the Kidney View
None Sarcomatoid Renal Cell Carcinoma View
None Stage III Renal Cell Cancer AJCC v8 View
None Stage IV Renal Cell Cancer AJCC v8 View
Keywords: